Endocrine Testing Market - Growth rate And Revenue Forecast 2018-2026 | Agilent Technologies, F-Hoffmann La Roche Ltd & SCIEX AB,



 Endocrine glands produce hormones straight into the bloodstream, making up the endocrine system. Endocrine hormone levels (such as follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol, insulin, and others) are measured in biological samples. These tests assist detect deviations in hormone production, such as hypersecretion (excess secretion) or hyposecretion (insufficient secretion), which can lead to endocrine problems such infertility, menopause, thyroid dysfunction, and others. Endocrine testing has become more common as a result of a variety of illnesses, including various types of diabetes and PCOS. The prevalence of diabetes and PCOS, for example, has increased dramatically, according to a report published in Current Diabetes Reports. As a result, an increase in the number of people with endocrine and metabolic problems is expected to propel the endocrine testing market forward.

The prevalence of endocrine and metabolic disorders is expected to increase, according to Transparency Market Research's latest report on the global endocrine testing market for the historical period 2017–2018 and forecast year 2019–2027. Furthermore, rising diabetes incidences are likely to propel the endocrine testing market forward.

The global endocrine testing market was worth US$ 5.5 billion in 2018, according to the report, and is expected to grow at a CAGR of 6.4 percent from 2019 to 2027.

Diabetes prevalence and incidence are increasing as a result of sedentary lifestyles and bad diets. According to a study published in Diabetes Research and Clinical Practice, the global diabetes prevalence was 463 million in 2019 and is expected to rise to 578 million by 2030. This is driving up demand for novel testing procedures that provide quick results. To meet these needs, the major players are spending in research & development operations in order to create and produce products that incorporate new technologies, hence promoting market growth.

The constant rise in the global geriatric population has a direct impact on the growth of endocrine testing solutions and techniques, as this demographic is very sensitive to a variety of health conditions, necessitating global illness management. Hernias, thyroid issues, and other hormone abnormalities can all be caused by getting older.

Menopause in women, loss of skeletal mass, androgen deficit in males, higher prevalence of type 2 diabetes, and a decrease in growth hormone are all changes in the endocrine system that occur with age. As a result, endocrine glands and organs go through a series of changes that alter hormone levels in an ageing person.

·         Agilent Technologies, Inc. is a leading player in the global endocrine testing industry.

  •          F-Hoffmann La Roche Ltd is a company that manufactures pharmaceuticals.
  •  ·         SCIEX AB, SCIEX AB, SCIEX AB, SC
  •  ·         Thermo Fisher Scientific is a company that specialises in scientific research and development.
  •  ·         Abbott Laboratories is a company that produces pharmaceuticals.
  •  
  •          Bio-Rad Laboratories is a company that specialises in biotechnology.

Comments

Popular posts from this blog

Quaternary Ammonium Compounds Market to Grow at USD 1.63 billion by 2027: COVID Impact & Post COVID Analysis, Business Opportunities, and Strategies

Butyraldehyde Market Trends, Growth, Demand, opportunities, Scope & Forecast 2027 by CMI

Glass Mat Thermoplastic Market : Size, Growth, Regional Analysis, And Market Area